Page last updated: 2024-08-23

vindesine and Mesothelioma

vindesine has been researched along with Mesothelioma in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (33.33)	18.7374
1990's	3 (50.00)	18.2507
2000's	1 (16.67)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ruffié, P	1
Cheng, E; Gralla, R; Kelsen, D; Martini, N	1
Bross, KJ; Fiebig, HH; Herrmann, F; Licht, T; Lübbert, M; Martens, C; Mertelsmann, R	1
Ashley, S; Hickish, T; Middleton, GW; Norton, A; O'Brien, ME; Priest, K; Smith, IE; Spencer, L	1
Airoma, G; Bianco, AR; Gridelli, C; Incoronato, P; Palazzolo, G; Pepe, R; Rossi, A	1
Boutin, C; Brambilla, C; Dabouis, G; Guérin, JC; Irisson, M; Jeannin, L; Le Caer, H; Paramelle, B; Roegel, E; Viallat, JR	1

Trials

1 trial(s) available for vindesine and Mesothelioma

Article	Year
Good symptom relief with palliative MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in malignant mesothelioma. Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9, Issue:3 Topics: Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Humans; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Mitomycin; Multivariate Analysis; Palliative Care; Survival Rate; Treatment Outcome; Vindesine	1998

Article

Year

Good symptom relief with palliative MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in malignant mesothelioma.

Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9, Issue:3

Topics: Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Female; Humans; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Mitomycin; Multivariate Analysis; Palliative Care; Survival Rate; Treatment Outcome; Vindesine

1998

Other Studies

5 other study(ies) available for vindesine and Mesothelioma

Article	Year
[New therapeutic options for mesothelioma]. Revue de pneumologie clinique, 2002, Volume: 58, Issue:5 Pt 2 Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Deoxycytidine; Doxorubicin; Folic Acid Antagonists; France; Gemcitabine; Humans; Mesothelioma; Mitomycin; Neoplasm Staging; Patient Selection; Pneumonectomy; Prognosis; Quinazolines; Radiotherapy, Adjuvant; Risk Factors; Survival Analysis; Thiophenes; Treatment Outcome; Vindesine	2002
Vindesine in the treatment of malignant mesothelioma: a phase II study. Cancer treatment reports, 1983, Volume: 67, Issue:9 Topics: Adult; Aged; Drug Evaluation; Female; Humans; Male; Mesothelioma; Middle Aged; Pericardium; Peritoneal Neoplasms; Pleural Neoplasms; Vinblastine; Vindesine	1983
Modulation of vindesine and doxorubicin resistance in multidrug-resistant pleural mesothelioma cells by tumor necrosis factor-alpha. Cytokines and molecular therapy, 1995, Volume: 1, Issue:2 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cell Survival; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Mesothelioma; Pleural Neoplasms; Recombinant Proteins; Transplantation, Heterologous; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Verapamil; Vindesine	1995
Mitomycin C and vindesine: an ineffective combination chemotherapy in the treatment of malignant pleural mesothelioma. Tumori, 1992, Dec-31, Volume: 78, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Female; Humans; Male; Mesothelioma; Middle Aged; Mitomycin; Pleural Neoplasms; Treatment Outcome; Vindesine	1992
Phase II trial of vindesine in malignant pleural mesothelioma. Cancer treatment reports, 1987, Volume: 71, Issue:2 Topics: Adult; Aged; Drug Evaluation; Female; Humans; Male; Mesothelioma; Middle Aged; Pleural Neoplasms; Vindesine	1987